Clinical Trial Update: Intravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's Disease [Phase 1]

View source ↗

Summary

Phase 1 trial investigating intravenous N-acetylcysteine for Parkinson's disease and Gaucher's disease has completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease
• Parkinson Disease

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: University of Minnesota | Conditions: Parkinson's Disease, Gaucher's Disease | Phase 1 | Status: COMPLETED | Results posted: 2013-08-02